🔎 Trials Near Me

Akèy › Karsinòm selil skuamèz tèt ak kou › Michigan › Ann Arbor

Etid klinik pou Karsinòm selil skuamèz tèt ak kou nan Ann Arbor, MI

12 etid pou Karsinòm selil skuamèz tèt ak kou ap chèche patisipan nan sit nan ak bò kote Ann Arbor (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Ap rekriteFaz 2/3
  • University of Michigan (Site # 161), Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06788990

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Ap rekriteFaz 3
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi lwen
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi lwen
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06589804

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

Ap rekriteFaz 3
  • Trinity Health St Joseph Mercy Ann Arbor, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07276399

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

Ap rekriteFaz 1/2
  • University of Michigan Rogel Cancer Center, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06385080

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Ap rekriteFaz 2
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • University of Michigan Rogel Cancer Center, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · 7 mi lwen
  • ak 5 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05136196

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Ap rekriteFaz 2
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • University of Michigan Rogel Cancer Center, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · 7 mi lwen
  • ak 6 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT02734537

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Ap rekriteFaz 2/3
  • University of Michigan Rogel Cancer Center, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT04333537

Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial

Ap rekriteFaz 2
  • University of Michigan Comprehensive Cancer Center, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07121595

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Ap rekriteFaz 1
  • University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 252010, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Jun 4, 2026 · NCT04777994

A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)

Ap rekriteFaz 2
  • University of Michigan Rogel Cancer Center, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Feb 2, 2026 · NCT05894083

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Ap rekriteFaz 1/2
  • University of Michigan, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Nov 4, 2025 · NCT05902988

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Ap rekriteFaz 1/2
  • University of Michigan, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2025 · NCT05941507

Etid Karsinòm selil skuamèz tèt ak kou nan lòt vil

Lòt etid nan Ann Arbor

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.